Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital [Phase 2]
Phase 2 trial updating administration of antibiotic prophylaxis for transperineal prostate biopsy at Cipto Mangunkusumo Hospital.
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies [Phase 2]
Phase 2 trial evaluating docetaxel and carboplatin in metastatic castration-resistant prostate cancer with DNA-repair deficiencies was termi…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluated cabazitaxel with or without carboplatin in patients with previously treated metastatic castration-resistant pros…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial [NA]
A completed clinical trial (HEIGHT) evaluating hypofractionated image-guided radiotherapy for prostate cancer with results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients [Phase 4]
Phase 4 clinical trial update evaluating androgen deprivation therapy effects on bone mineral density in prostate cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer [Phase 3]
Phase 3 trial evaluating hormone suppression with or without docetaxel plus radiation therapy in high-risk prostate cancer; results posted a…
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule [NA]
Clinical trial update on high-dose-rate prostate brachytherapy with dose escalation to the dominant intra-prostatic nodule; study completed …
-
FDA approval · 2021-07-14FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for ERLEADA (apalutamide) submitted by Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches [NA]
A prospective randomized trial comparing office-based MR-guided prostate biopsy approaches; the study was terminated and results were posted…
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC [Phase 2]
A Phase 2 trial evaluating sipuleucel-T with or without radium-223 in men with asymptomatic or minimally symptomatic bone-metastatic castrat…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels [Phase 2]
Phase 2 trial comparing abiraterone acetate plus ADT to apalutamide to both in advanced prostate cancer with non-castrate testosterone; stud…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Prostvac in Patients With Biochemically Recurrent Prostate Cancer [Phase 2]
Phase 2 trial update for Prostvac in biochemically recurrent prostate cancer; results completed with posted results in 2021.
-
FDA approval · 2021-07-02FDA Approved: ABIRATERONE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Abiraterone acetate (generic Abiraterone) from Hikma Pharmaceuticals USA, Inc., expanding access…
-
FDA approval · 2021-07-01FDA Approved: DOCETAXEL — Original Application (Gland Pharma Limited)
FDA approves Gland Pharma Limited's generic docetaxel as an Original Application, adding a new generic option for cancer chemotherapy.
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence [Phase 3]
Phase 3 trial comparing F-18-PSMA-1007 with F-18-Fluorocholine PET in patients with biochemical recurrence of prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer [Phase 3]
Phase 3 clinical trial update on hormone therapy for patients with rising PSA after radiation therapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer [Phase 2]
Phase 2 trial evaluating panobinostat for metastatic hormone-refractory prostate cancer has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. [Phase 2]
Phase 2 clinical trial evaluating estetrol's impact on testosterone suppression and quality of life in prostate cancer patients on an LHRH a…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer [Phase 2]
Phase 2 trial investigating VERU-944 to reduce hot flashes in men with metastatic prostate cancer has completed with posted results.
-
FDA label_change · 2021-06-17FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
FDA supplemental application for ZOLADEX (goserelin) submitted by TerSera Therapeutics LLC, likely related to labeling changes for the produ…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer [NA]
Clinical trial update for MRI-guided lattice extreme ablative dose radiotherapy in prostate cancer, with completed status and results posted…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer [Phase 3]
Phase 3 clinical trial update evaluating 18F-DCFPyL PET/CT imaging for suspected recurrence of prostate cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating metformin in patients with metastatic castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients [Phase 2]
Phase 2 feasibility trial evaluating chemotherapy with docetaxel and prednisone for elderly patients with castration-resistant metastatic pr…